K892856

Substantially Equivalent

NEWMARK(TM) CORONARY ARTERY BYPASS GRAFT MARKERS

Applicant
Acacia Laboratories, Inc.
Product code
KRI
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Santa Ana, CA, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.